Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:07:36.837Z.
Consensus retrieved: 2026-10-06T13:38:52.173Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:07:36.837Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 564e985820cc4d82a577ec1dab8a2942c5d07d58deba224fe20754c365e89b20
Forward PE Ratio (N/A) = Dated Quote Price ($1.78) / Consensus Forward EPS ($-1.02)
FORWARD PE RATIO
N/A
Pulmonx Corporation
Market Cap
$75.18M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Pulmonx Corporation (LUNG) | $75.18M | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | N/A |
| Outset Medical, Inc. (OM)vs › | $76.74M | N/A |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | N/A |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | N/A |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $1.78, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.02 | $-1.03 – $-1.01 | 4 | n/m |
| 2027-12-31 | $-0.94 | $-0.97 – $-0.90 | 4 | n/m |
| 2028-12-31 | $-0.77 | $-0.94 – $-0.64 | 4 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
